Get the Stockscreener App
0.00
100.00%
-2.07
After Hours:
2.12
2.12
+
Immunoprecise Antibodies Ltd stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
ImmunoPrecise Antibodies Ltd is an AI-driven biotherapeutic research, technology and scientifically robust life science company focused on the discovery and development of next-generation biologics. The Company combines scientific expertise with proprietary technologies such as its LENSai platform to accelerate drug discovery and improve decision-making across complex biological systems. IPA has several subsidiaries in North America and Europe, supporting global partners in advancing novel therapeutics, diagnostics, and translational research.
See More
Previous Close:
$2.07
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$89.08M
Revenue:
$16.77M
Net Income/Loss:
$-11.87M
P/E Ratio:
0.00
EPS:
-0.4742
Net Cash Flow:
$-5.90M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$2.34
52-Week Range:
$0.00
$3.2459
Immunoprecise Antibodies Ltd Stock (IPA) Company Profile
Name
Immunoprecise Antibodies Ltd
Sector
Industry
Phone
-
Address
-
Compare IPA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IPA
Immunoprecise Antibodies Ltd
|
0.00 | 89.08M | 16.77M | -11.87M | -5.90M | -0.4742 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Immunoprecise Antibodies Ltd Stock (IPA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-22 | Initiated | H.C. Wainwright | Buy |
| Oct-25-21 | Initiated | The Benchmark Company | Buy |
Immunoprecise Antibodies Ltd Stock (IPA) Latest News
Can trapped investors hope for a rebound in ImmunoPrecise Antibodies Ltd.Trade Performance Summary & Consistent Income Trade Ideas - Newser
Is ImmunoPrecise Antibodies Ltd. stock bottoming outTrade Analysis Report & Real-Time Volume Surge Alerts - Newser
Should I set a stop loss on ImmunoPrecise Antibodies Ltd.Weekly Trend Report & Trade Opportunity Analysis - خودرو بانک
What the charts say about ImmunoPrecise Antibodies Ltd. todayJuly 2025 Short Interest & Weekly Return Optimization Alerts - Newser
Is ImmunoPrecise Antibodies Ltd. stock good for income investorsPortfolio Performance Report & Fast Momentum Entry Tips - خودرو بانک
Risk adjusted return profile for ImmunoPrecise Antibodies Ltd. analyzedBond Market & Long-Term Growth Plans - Newser
Real time scanner hits for ImmunoPrecise Antibodies Ltd. explainedQuarterly Growth Report & High Accuracy Buy Signal Tips - Newser
A | Does ImmunoPrecise Antibodies Ltd. align with a passive investing strategyJuly 2025 Fed Impact & High Return Trade Opportunity Guides - خودرو بانک
Multi asset correlation models including ImmunoPrecise Antibodies Ltd.2025 Trade Ideas & Fast Exit and Entry Trade Guides - Newser
Will ImmunoPrecise Antibodies Ltd. stock recover after recent drop2025 Big Picture & Advanced Swing Trade Entry Plans - Newser
Published on: 2025-09-05 01:55:04 - Newser
Real time alert setup for ImmunoPrecise Antibodies Ltd. performanceQuarterly Market Summary & Weekly Chart Analysis and Guides - Newser
Does ImmunoPrecise Antibodies Ltd. align with a passive investing strategy2025 Technical Patterns & Smart Swing Trading Alerts - خودرو بانک
Three new option listings and one option delisting on September 4th - TipRanks
ImmunoPrecise Antibodies Ltd. recovery potential after sell offMarket Activity Recap & Free Weekly Chart Analysis and Trade Guides - Newser
Can ImmunoPrecise Antibodies Ltd. hit a new high this monthTrade Exit Summary & Verified Chart Pattern Trade Signals - Newser
Relative strength of ImmunoPrecise Antibodies Ltd. in sector analysisJuly 2025 Analyst Calls & Daily Technical Stock Forecast Reports - Newser
Strategies to average down on ImmunoPrecise Antibodies Ltd.Stop Loss & Stock Portfolio Risk Control - Newser
Using Ichimoku Cloud for ImmunoPrecise Antibodies Ltd. technicalsMarket Movement Recap & Low Risk Investment Opportunities - Newser
ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to “HYFT” - PharmiWeb.com
Pattern recognition hints at ImmunoPrecise Antibodies Ltd. upsideJuly 2025 Gainers & Weekly High Conviction Trade Ideas - Newser
ImmunoPrecise Antibodies Ltd. has Changed its Name to MindWalk - MarketScreener
ImmunoPrecise Antibodies Ltd. has Changed its Ticker to HYFT from IPA - MarketScreener
ImmunoPrecise Antibodies rebrands as MindWalk, changes ticker to HYFT - Investing.com
Technical signs of recovery in ImmunoPrecise Antibodies Ltd.2025 Market WrapUp & Safe Entry Point Identification - Newser
ImmunoPrecise Antibodies shares rise 7.25% premarket after announcing participation in H.C. Wainwright Global Investment Conference. - AInvest
Heatmap analysis for ImmunoPrecise Antibodies Ltd. and competitors2025 EndofYear Setup & Verified Chart Pattern Signals - Newser
Is it time to cut losses on ImmunoPrecise Antibodies Ltd.2025 Technical Overview & Low Volatility Stock Recommendations - Newser
Can you recover from losses in ImmunoPrecise Antibodies Ltd.2025 Investor Takeaways & Technical Buy Zone Confirmation - Newser
ImmunoPrecise Antibodies (IPA) Stock Price, News & Analysis - MarketBeat
What machine learning models say about ImmunoPrecise Antibodies Ltd.July 2025 Gainers & Technical Entry and Exit Tips - Newser
What’s the recovery path for long term holders of ImmunoPrecise Antibodies LtdQuarterly Performance Summary & Low Risk High Win Rate Stock Picks - Newser
What’s the recovery path for long term holders of ImmunoPrecise Antibodies Ltd.Portfolio Update Report & Expert Approved Momentum Trade Ideas - Newser
ImmunoPrecise Antibodies to Present at Global Investment Conference - TipRanks
ImmunoPrecise Antibodies' Strategic Visibility at H.C. Wainwright Conference: A Catalyst for Institutional Interest? - AInvest
ImmunoPrecise Antibodies to Participate at H.C. Wainwright's 27th Annual Global Investment Conference in New York - The Globe and Mail
Can ImmunoPrecise Antibodies Ltd. sustain its profitabilityMarket Volume Summary & Consistent Profit Focused Trading Strategies - خودرو بانک
Immunoprecise Antibodies Ltd Stock (IPA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):